When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in ...

Hormone therapy uses medication to lower or block ... These systems use nanoparticles to more effectively deliver cancer drugs. Some examples of cancer drugs that may use a nanoparticle-based ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult pat ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

UCR scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers ...

And we've seen some data that perhaps the hormone therapies ... the question of whether we should be using these drugs during cancer therapy, but rather, patients who have aggressive diabetes ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.